References
- Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome: a new world-wide definition: a consensus statement from the international diabetes federation. Diabet Med J Br Diabet Assoc. 2006 May; 23(5): 469-80. PubMed | Google Scholar
- Alshehri AM. Metabolic syndrome and cardiovascular risk. J Fam Community Med. 2010 Aug; 17(2): 73. PubMed | Google Scholar
- Fox CS. Cardiovascular disease risk factors, Type
2 Diabetes Mellitus, and the Framingham Heart Study.
Trends Cardiovasc Med. 2010 Apr; 20(3): 90. PubMed | Google
Scholar
- Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen
K, Pyorala K. Prevalence of the metabolic syndrome
and its relation to all-cause and cardiovascular mortality
in Nondiabetic European Men and
Women. Arch Intern Med. 2004 May 24; 164(10): 1066-76. PubMed | Google
Scholar
- Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K,
Nissén M et al. Cardiovascular morbidity and mortality associated with
the metabolic syndrome. Diabetes Care. 2001 Apr 1;
24(4): 683?9. PubMed | Google
Scholar
- Lakka H-M, Laaksonen DE, Lakka TA, Niskanen LK,
Kumpusalo E, Tuomilehto J et al. The metabolic syndrome
and total and cardiovascular disease mortality in middle-aged
men. JAMA. 2002 Dec 4;
288(21): 2709-16. PubMed | Google
Scholar
- Stern MP, Williams K, González-Villalpando C, Hunt KJ, Haffner SM. Does the Metabolic Syndrome Improve Identification of Individuals at Risk of Type 2 Diabetes and/or Cardiovascular Disease. Diabetes Care. 2004 Nov 1; 27(11): 2676-81. PubMed | Google Scholar
- World Health Organization. Global
action plan for the prevention and control of noncommunicable
diseases: 2013-2020. Accessed on July 10 2017.
- Grunfeld C, Pang M, Doerrler W, Shigenaga JK, Jensen P, Feingold KR. Lipids, lipoproteins, triglyceride clearance and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab. 1992 May; 74(5): 1045-52. PubMed | Google Scholar
- Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm
DJ et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and
insulin resistance in patients receiving HIV protease inhibitors. AIDS
Lond Engl. 1998 May 7; 12(7): F51-58. PubMed | Google
Scholar
- Palella FJ, Delaney KM, Moorman AC, Loveless MO,
Fuhrer J, Satten GA et al. Declining morbidity and mortality among patients
with advanced human immunodeficiency virus infection, HIV Outpatient
Study Investigators. N Engl J Med. 1998 Mar 26; 338(13): 853-60. PubMed | Google
Scholar
- Ete T, Ranabir S, Thongam N, Ningthoujam B, Rajkumar N, Thongam B. Metabolic abnormalities in human immunodeficiency virus patients with protease inhibitor-based therapy. Indian J Sex Transm Dis. 2014; 35(2): 100-3. PubMed | Google Scholar
- Palacios R, Santos J, González M, Ruiz J, Márquez M. Incidence and prevalence of the metabolic syndrome in a cohort of naive HIV-infected patients: prospective analysis at 48 weeks of highly active antiretroviral therapy. Int J STD AIDS. 2007 Mar 1; 18(3): 184-7. PubMed | Google Scholar
- Alberti KGM, Zimmet P, Shaw J. The metabolic syndrome:
a new worldwide definition. The Lancet. 2005 Sep; 366(9491):
1059-62. PubMed | Google
Scholar
- Isezuo SA, Ezunu E. Demographic and clinical correlates of metabolic syndrome in Native African type-2 diabetic patients. J Natl Med Assoc. 2005 Apr; 97(4): 557. PubMed | Google Scholar
- Fezeu L, Balkau B, Kengne A-P, Sobngwi E, Mbanya JC. Metabolic syndrome in a sub-Saharan African setting: central obesity may be the key determinant. Atherosclerosis. 2007 Jul; 193(1): 70. PubMed | Google Scholar
- Omuse G, Maina D, Hoffman M, Mwangi J, Wambua C,
Kagotho E et al. Metabolic syndrome and its predictors
in an urban population in Kenya: a cross-sectional
study. BMC Endocr Disord. 2017; 17: 37. Google
Scholar
- Kaduka LU, Kombe Y, Kenya E, Kuria E, Bore JK,
Bukania ZN et al. Prevalence of metabolic syndrome among an urban population
in Kenya. Diabetes Care. 2012 Apr; 35(4): 887-93. PubMed | Google
Scholar
- Dimodi HT, Etame LS, Nguimkeng BS, Mbappe FE, Ndoe
NE, Tchinda JN et al. Prevalence of metabolic syndrome
in HIV-infected Cameroonian Patients. World J AIDS.
2014; 4: 85-92. Google
Scholar
- Kagaruki G, Kimaro G, Mweya C, Kilale A, Mrisho
R, Shao A et al. Prevalence and risk factors of metabolic
syndrome among individuals living with HIV and receiving
antiretroviral treatment in
Tanzania. Br J Med Med Res. 2015 Jan 10; 5(10): 1317-27. Google
Scholar
- Berhane T, Yami A, Alemseged F, Yemane T, Hamza
L, Kassim M et al. Prevalence of lipodystrophy and metabolic syndrome
among HIV positive individuals on Highly Active Anti-Retroviral treatment
in Jimma, South West Ethiopia. Pan Afr Med J. 2012; 13: 43. PubMed | Google
Scholar
- Erasmus RT, Soita DJ, Hassan MS, Blanco-Blanco
E, Vergotine Z, Kegne AP et al. High prevalence of diabetes mellitus
and metabolic syndrome in a South African coloured population: baseline
data of a study in Bellville, Cape Town. South Afr Med J Suid-Afr Tydskr
Vir Geneeskd. 2012 Oct 8;102(11 Pt 1): 841-4. PubMed | Google
Scholar
- Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009 Oct 20; 120(16): 1640-5. PubMed | Google Scholar
- Samaras K, Wand H, Law M, Emery S, Cooper D, Carr A. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein and [corrected] hypoadiponectinemia. Diabetes Care. 2007 Jan; 30(1): 113-9. PubMed | Google Scholar
- Jericó C, Knobel H, Montero M, Ordoñez-Llanos J, Guelar A, Gimeno JL et al. Metabolic syndrome among HIV-infected patients: prevalence, characteristics and related factors. Diabetes Care. 2005 Jan; 28(1): 132-7. PubMed | Google Scholar
- Hansen BR, Petersen J, Haugaard SB, Madsbad S,
Obel N, Suzuki Y et al. The prevalence of metabolic syndrome in Danish
patients with HIV infection: the effect of antiretroviral therapy. HIV
Med. 2009 Jul 1; 10(6): 378-87. PubMed | Google
Scholar
- Santos A-C, Barros H. Impact of metabolic syndrome definitions on prevalence estimates: a study in a Portuguese community. Diab Vasc Dis Res. 2007 Dec 1; 4(4): 320-7. PubMed | Google Scholar
- Paula AA, Falcão MC, Pacheco AG. Metabolic syndrome in HIV-infected individuals: underlying mechanisms and epidemiological aspects. AIDS Res Ther. 2013 Dec 13; 10(1): 32. PubMed | Google Scholar
- Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzlaff
BM, Brunzell JD et al. Intra-abdominal fat is a major
determinant of the National Cholesterol Education Program
adult treatment panel III
criteria for the metabolic syndrome. Diabetes. 2004
Aug; 53(8): 2087-94. PubMed | Google
Scholar
- Price J, Hoy J, Ridley E, Nyulasi I, Paul E, Woolley I. Changes in the prevalence of lipodystrophy, metabolic syndrome and cardiovascular disease risk in HIV-infected men. Sex Health. 2015 Jun; 12(3): 240-8. PubMed | Google Scholar